Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$146.87
▼ $0.28 (−0.19%) today
Markets closed · 8:32pm ET

MRK Coverage

Page 28
10:05am ET
Health and Healthcare

Merck Moves Ahead With Late-Stage Trial Win

Shares of Merck had a boost early Monday after the firm announced that its Phase 3 trial of Keytruda for the treatment of metastatic non-small cell lung cancer met its primary endpoint.

MRK
Chris Lange
10:05am ET
Health and Healthcare

What Has Tanked Incyte and NewLink Genetics

Incyte saw its shares make a sharp left turn on Friday after the firm gave an update on its late-stage collaboration with Merck. NewLink Genetics felt the sting as well.

Chris Lange
9:10am ET
Health and Healthcare

Short Sellers Hike Bets in Major Pharma

The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks increased.

Chris Lange